Plenary Speakers
Joshua LaBaer, PhD
Affiliation: ASU- The Biodesign Institute (USA)
Title: New Methods for Cell-Free Presentation of Proteins for Functional Analysis.
Jürgen Cox, PhD
Affiliation: Max Planck Institute of Biochemistry (Germany)
Title: MaxDIA enables library-based and library-free data-independent acquisition proteomics.
Jacek R. Wisniewski, PhD
Affiliation: Max Planck Institute of Biochemistry (Germany)
Title: Global quantitative proteomics using the FASP and TPA methods.
Alan Wells, PhD
Affiliation: University of Pittsburgh (USA)
Title: The dermal matrix: a proteomic wonderland.
Xian Chen, PhD
Affiliation: University of North Carolina at Chapel Hill (USA)
Jeremiah Morrissey, PhD
Affiliation: Washington University in St. Louis (USA)
Title: Maximizing assay sensitivity and specificity to minimize false negatives and false positives for patient wellbeing.
Chris Overall, PhD
Affiliation: Canada Research Chair in Protease Prote- omics and Systems Biology (Canada)
Title: The Proteolytic Landscape of SARS-CoV-2 3CLpro in COVID-19.
Merry L. Lindsey, PhD
Affiliation: University of Nebraska Medical Center (USA)
Title: Proteomics reveals protein targets to limit wall thinning after myocardial infarction.
Daniel Martins-de-Souza, PhD
Affiliation: University of Campinas (Brazil)
Title: SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability.
Martin Pabst, PhD
Affiliation: Delft University of Technology (The Netherlands)
Title: A systematic study to maximise proteome coverage while minimizing artefacts through sample preparation procedures in yeast large-scale proteomics.
Martin R. Larsen, PhD
Affiliation: University of Southern Denmark (Denmark)
Title: Comprehensive PTM enrichment strategies applied to studying signaling pathways.